The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Addiction Medication Offers New Hope for Long COVID Patients
Featured in Neurology Neuroscience·May 7, 2024
New Research Aims to Unravel Both ME/CFS and Long COVID
Miriam E. Tucker
Medscape Medical News > Conference News
December 21, 2023
A key to a ‘faulty’ lock: Why Aussie researchers are excited about naltrexone for CFS
Ausdoc.com
31 July 2023
https://www.ausdoc.com.au/news/a-key-to-a-faulty-lock-why-aussie-researchers-are-excited-about-naltrexone-for-cfs/
Off-Label Meds: Promising Long COVID Treatments?
Medscape
28 July 2023
https://www.medscape.com/viewarticle/994728?form=fpf
With a lack of FDA-approved treatments, doctors who treat long COVID are turning to off-label use of drugs designed for addiction, diabetes, and other conditions.The FDA approves each drug to treat a specific condition. Off-label use, which is legal and common, allows doctors to prescribe drugs for another use.
Queensland scientists push for new national treatment guidelines for chronic fatigue syndrome
ABC News
12 June 2023
https://www.abc.net.au/news/2023-06-13/griffith-university-scientists-researching-chronic-fatigue-mecfs/102471386